Board to consider fund raise via equity or equity-linked securities on Aug 5

Sarda Proteins has informed BSE about a board meeting on August 5, 2026. The board will consider raising funds through equity shares, convertible bonds, debentures, convertible warrants, or preference shares. Possible modes include rights issue, private placement, preferential issue, or QIP. No size, pricing, or end use of funds has been disclosed yet.